Topic

UnitedHealthcare (UnitedHealth Group)

A collection of 1322 issues

How to Get Acthar Gel Approved by UnitedHealthcare in California: Prior Authorization Guide & Appeal Process

Answer Box: Getting Acthar Gel Covered by UnitedHealthcare in California UnitedHealthcare requires prior authorization for Acthar Gel (repository corticotropin injection) with strict medical necessity criteria limited to infantile spasms under age 2 and opsoclonus-myoclonus syndrome. Step therapy requiring documented failure of high-dose corticosteroids is mandatory for most conditions. If denied,
6 min read

How to Get Fabrazyme (Agalsidase Beta) Approved by UnitedHealthcare in Washington: 2025 Timeline & Appeal Guide

Answer Box: Getting Fabrazyme Covered by UnitedHealthcare in Washington UnitedHealthcare requires prior authorization for Fabrazyme (agalsidase beta) in Washington, typically decided within 1-3 business days for standard requests once complete documentation is received. Key requirements include genetic testing confirming Fabry disease, specialist prescription, and clinical evidence of organ involvement. If
7 min read

How to Get Cosentyx (secukinumab) Covered by UnitedHealthcare in Pennsylvania: Complete PA Guide with Appeals Process

Answer Box: Getting Cosentyx Covered by UnitedHealthcare in Pennsylvania UnitedHealthcare requires prior authorization for Cosentyx (secukinumab) with step therapy through preferred biologics first. Submit PA via the UHCprovider.com portal with diagnosis documentation, prior treatment failures, and clinical response data. If denied, Pennsylvania's new external review program overturns
6 min read

Do You Qualify for Arcalyst (rilonacept) Coverage by UnitedHealthcare in California? Decision Tree & Next Steps

Quick Answer: If you have CAPS, DIRA, or recurrent pericarditis and have failed colchicine/NSAIDs, you likely qualify for Arcalyst coverage through UnitedHealthcare in California. Submit prior authorization through your specialist with documented treatment failures. If denied, California's strong Independent Medical Review process overturns ~68% of specialty drug
4 min read

Work With Your Doctor to Get Evkeeza (evinacumab-dgnb) Approved by UnitedHealthcare in New York: Complete Prior Authorization Guide

Answer Box: Getting Evkeeza Covered by UnitedHealthcare in New York Evkeeza (evinacumab-dgnb) requires prior authorization from UnitedHealthcare for homozygous familial hypercholesterolemia (HoFH) patients ≥5 years old. Fastest path: Work with your specialist to submit a complete PA request including genetic confirmation of HoFH, documented failure of maximally tolerated therapy (statin
6 min read

Work With Your Doctor to Get Arikayce Covered by UnitedHealthcare in Virginia: Complete Provider Partnership Guide

Answer Box: Your Path to Arikayce Coverage in Virginia UnitedHealthcare requires prior authorization for Arikayce (amikacin liposome inhalation) based on refractory MAC lung disease criteria: ≥6 months failed multidrug therapy with persistent positive cultures. Work with your pulmonologist or infectious disease specialist to document treatment failure, compile culture results, and
7 min read

Get Cabometyx (Cabozantinib) Covered by UnitedHealthcare in New Jersey: Complete PA Guide, Appeals, and IHCAP Process

Answer Box: Getting Cabometyx Covered by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization (PA) for Cabometyx (cabozantinib) through OptumRx for all cancer indications. Fastest path: Have your oncologist submit PA via the UnitedHealthcare Provider Portal with diagnosis confirmation, prior therapy details, and RECIST imaging. If denied, New Jersey residents
6 min read

How to Get Palynziq (pegvaliase-pqpz) Covered by UnitedHealthcare in Florida: Complete Prior Authorization and Appeals Guide

Quick Answer: Getting Palynziq Covered by UnitedHealthcare in Florida UnitedHealthcare requires prior authorization for Palynziq (pegvaliase-pqpz) in Florida, managed through OptumRx specialty pharmacy. To get approved, you need: confirmed PKU diagnosis, blood phenylalanine >600 µmol/L, active phenylalanine-restricted diet, documented sapropterin trial failure, and REMS program enrollment. Your prescriber
6 min read